Board of Directors New Member

  • -
Board of Directors welcomes Thomas O'Neill

Board of Directors New Member

Thomas O’Neill Joining ABS Board of Directors

ABS is very proud to announce the newest member of the Board of Directors, Thomas O’Neill.  Tom brings with him a wealth of knowledge and experience.

Tom founded Sandler O’Neill + Partners and was also lead for practice groups of notable companies such as Rothschild and Bear Stearns.

Advanced Bifurcation Systems CEO, Charles Laverty stated that ABS is thrilled to have Thomas join.  Also stating that they are thrilled to have his experience in medical devices and that this makes him particularly qualified.

The press release can be found here.

 


  • -
Scott King, VP of Regulatory Affairs

Welcoming Scott King

Category : Announcing , News

Scott King joins Advanced Bifurcation Systems 

Advanced Bifurcation Systems (ABS) announced that Scott King has joined the leadership team as Vice President of Regulatory Affairs and Chief Compliance Officer.

ABS is a clinical stage, medical device company whose stenting platform overcomes the limitations of current approaches for the treatment of bifurcation lesions in coronary angioplasties.

Mr. King will direct ABS’s regulatory strategy and interface with the FDA as ABS seeks approval of its platform. “Scott brings to ABS over two decades of regulatory affairs and quality assurance experience, with a proven track record leading regulatory affairs for innovative medical device companies,” said Charles Laverty, CEO of Advanced Bifurcation Systems. “His industry expertise will be invaluable as we seek regulatory approval. We look forward to his contributions as a key member of our leadership team.”

Extensive Experience

Mr. King has extensive experience in setting global regulatory strategy, registration and pre-market notification, agency communications, and inspection and audit management. Prior to joining ABS, Mr. King was VP, Regulatory and Quality Affairs and Chief Compliance Officer at Ceterix Orthopaedics, which produces surgical tools for tissue joint injuries. There King developed the regulatory strategy and prepared the successful submission for the Company’s NovoStitch Plus Meniscal Repair System.

Mr. King also drafted and released procedure for evaluating post market product changes, and was responsible for evaluating changes and establishing regulatory strategies to support product research and development.

Before ABS

Prior to joining Ceterix Orthopaedics, Mr. King was Sr. Manager, Product Quality Assurance at Intuitive Surgical, which develops robotic-assisted technologies, tools and services that bring enhanced predictability to surgery.

King’s earlier roles include Associate Director, Regulatory Affairs and Quality Assurance at XDx Molecular Diagnostics (now CareDx), a molecular diagnostics company, and Manager, Quality Systems, at Kyphon (now Medtronic), a maker of spinal treatments.

Mr. King has a BS Biology from James Madison University in Virginia.


  • -
Biospace profile for ABS

ABS now on Biospace

Biospace Profile

We are happy to announce that we are now profiled on Biospace.com.  This is a web space to go to for industry news and careers.

This site offers an extensive industry news and information on life sciences.  Biospace posts daily on breaking news in this field.  Which in turn keeps their followers and investors versed in the latest in the medical, pharmaceutical and biotech fields.

A Very Useful Site for the Industry

They also have career news and advice that is industry specific.  Career resources and support are also available.  You can sign up for newsletters.  Also their flagship GenePool of career and news updates that allows their feed to go directly to your inbox.

Advanced Bifurcations Systems has a career section and a profile on their site.  You can find out our latest offerings and find out more company information.

Please feel free to connect with us on any of our social media platforms.